Ashish Jain is a seasoned professional in the field of translational science and clinical development, currently serving as Vice President and Head of Translational Science for Rare Diseases at AstraZeneca since July 2022. Jain's previous roles include Vice President and Head of Experimental Medicine at EMD Serono, where responsibilities encompassed solid tumor immunotherapy and clinical immunology, and Senior Principal Scientist at Merck, overseeing projects across various therapeutic areas. Jain's extensive research background includes leadership of the Clinical Immunology Unit at the National Institutes of Health, focusing on rare immune system disorders. Jain holds an MD from Stony Brook University, along with specialized training and research fellowships at prestigious institutions, demonstrating a strong foundation in medicine and clinical research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices